The Electric Car You’ve Never Heard Of May Upend Tesla

Posted by Ray Tetreault

Oct 3, 2017 2:07:06 PM

To the casual observer, it may seem as if Tesla will be the end-all be-all for our future transportation needs. The reveal of the market-priced Model 3 earlier this year has led some to ring the victory bell, announcing Tesla as the unheralded king of electronic transportation. Not only will it be providing your residential vehicles, it will also be tackling the commercial and public transit sectors as well. Of course, there are other options out there; Nissan will be releasing its next-generation Leaf soon, Chevy continues to push its Bolt and Volt lines, and Volkswagen promises to have 30 electric models released as soon as 2025. Even China has its heavyweight in the mix, BYD, short for Build Your Dreams. Yet, you would be hard-pressed to find anyone who wouldn’t think of Tesla first and foremost when asked about electric transportation. However, viewing the playing field through the scope of competitive strategy exposes an entirely different conclusion.

Read More

Don’t Underestimate WeWork

Posted by Ken Sawka

Sep 20, 2017 3:28:18 PM

Co-Written by Robin Kao

Read More

Topics: Consumer Goods, Innovation, Competitive Strategy

Upcoming Event: FGH Academy of Competitive Intelligence Certification Program Boston October 23-27, 2017

Posted by Fuld + Company

Sep 19, 2017 3:58:14 PM

Join Leonard Fuld, Dr. Ben Gilad, and Ken Sawka in Boston, MA for their core certification courses. Competitive intelligence is not collecting random information. It's developing a skilled view of competitive risks and opportunities. Choose courses based on your interest or take all courses to become a certified CIP®.

Hotel discounted rate cut-off September 28, 2017

October registration October 23-27

Read More

Topics: Competitive Intelligence, Events, FGH Academy of Competitive Intelligence, Fuld, Leonard

Pharmaceutical Perspective: Considerations When Tapping into A New Market

Posted by Malini Solanki

Sep 14, 2017 10:15:52 AM

The U.S. is the largest market for pharmaceuticals, accounting for 30 to 40 percent of the worldwide market. However, newer smaller markets are on the rise for new drug products.

Read More

Topics: New Market Entry, Pharma

What Medical Marijuana Means for Pharma Companies

Posted by Karl Varkey

Sep 8, 2017 9:37:53 AM

Read More

Topics: Innovation, Competitive Strategy, Pharmaceuticals

The Importance of Leadership and Brand Alignment

Posted by Allie Hackel

Aug 24, 2017 11:32:00 AM

On August 14, 2017, Kenneth C. Frazier, Chairman and CEO of Merck, resigned from President Trump’s American Manufacturing 

Read More

Topics: pharmaceutical, risk management

The Future of the Connected Car Industry

Posted by Ben Price

Aug 9, 2017 3:06:21 PM

 

The recent launch of Tesla’s mass-market vehicle, the Model 3, has people wondering what the connected car landscape will look like in the future. Tesla projects exponential sales growth, vastly exceeding current production capabilities. While Tesla is at the forefront of the headlines, other automobile manufactures, entertainment platform companies, data management companies, software and hardware companies scramble to dictate standards and stay relevant to the market dynamics of the automobile. What does this mean for the future of the automobile? Companies will partner, merge and acquire to avoid obsolescence caused by this breakneck speed of technological automobile innovation.

Read More

Topics: Innovation, Competitive Strategy

Injecting a new Healthcare Model: The Pharmacist-Physician Team

Posted by Laura Ruth

Aug 1, 2017 9:16:59 AM

With less than three years until the re-evaluation of HealthyPeople2020 Immunization targets, Benjamin Blumi, Senior Vice President of the American Pharmacists Association (APhA) Foundation, and his colleagues reported a dramatic breakthrough: in a study run from the fall of 2016 through spring of 2016, the number of pharmacist-administered adult vaccinations increased by more than 40 percent.  A significant contributor to this success was Project IMPACT (IMProve American Communities Together), which features real time, bidirectional immunization information systems (IIS). The full breadth of this success, however, lies not exclusively with technology but with the adept interaction between information systems and patient-care processes.

Read More

Topics: Healthcare, Pharmaceuticals

Transparency into Drug Pricing: Can it help with the high drug costs?

Posted by Malini Solanki

Jul 27, 2017 3:48:16 PM

Drug pricing became a topic of common and passionate interest in 2015 when Martin Shkreli, then CEO of Turing Pharmaceuticals, dramatically increased the price of a single Daraprim tablet - from $13.50 to $750.00, the price of an average lunch to that of a large household appliance. The interest intensified in 2016, when Mylan increased the cost of the EpiPen by 400 percent. Public outcry was intense and politicians were forced to act, holding hearings that are only now rivaled by probes into Russian election interference.

Read More

Topics: Healthcare, Competitive Strategy, Pharmaceuticals

What’s a Health Industry Business Strategist To Do?

Posted by Ken Sawka

Jul 26, 2017 3:38:49 PM

How do you set a business strategy in a highly-regulated market in which you don’t have complete control over what you can charge a segment of your customers, in which funds promised to your business by government agencies may be taken away, and in which rules governing what products you can sell can change at any time? Such is the life of strategic planners in U.S. health insurance companies.

Read More

Topics: Healthcare, Competitive Strategy

Fuld + Company Blog

The material on this page draws on the research and experience of Fuld + Company thought leaders, consultants and others. Learn more about our expertise here.

Request for Information

If you'd like someone at Fuld to contact you regarding your strategic competitive challenges, fill out the form below.